| 688 |
Centers for Disease Control and Prevention |
Html |
en |
How We Can Protect Our Children From Secondhand Smoke - Smoking & Tobacco Use |
These brochures will educate those who care for children on the health dangers of secondhand smoke (SHS). The goal is to deliver culturally relevant information to various populations that will motivate them to reduce SHS exposure to children by making their homes and cars smoke-free. |
| SHS exposure | 0.82993 |
| various populations | 0.584061 |
| children | 0.234383 |
|
| health dangers | 0.638095 |
| secondhand smoke | 0.689255 |
|
CLICK HERE |
| 4466 |
Centers for Disease Control and Prevention |
Html |
en |
Safe Teen Driving | CDC Features |
CDC's Injury Center is committed to preventing teen crashes and related deaths and injuries. |
| overall fatal crashes | 0.47119 |
| teen deaths | 0.448794 |
| teen driver | 0.742619 |
| teen crashes | 0.513101 |
| Fatal Night Crashes | 0.476837 |
| mandatory holding period | 0.407428 |
| newly licensed teens | 0.411203 |
| Youth Risk Behavior | 0.398146 |
| Single Vehicle Crashes | 0.475325 |
| GDL Planning Guide | 0.44055 |
| driver nonfatal crashes | 0.489491 |
| driver licensing practices | 0.41813 |
| implement actionable plans | 0.402243 |
| young driver | 0.376705 |
| Primary enforcement seat | 0.40311 |
| new CDC study | 0.412954 |
| health outcome data | 0.399207 |
| Prevention Status Reports | 0.397286 |
| teen drivers | 0.909645 |
| new driver | 0.383795 |
| GDL night | 0.39155 |
| teen drivers ages | 0.535616 |
| parents | 0.422098 |
| parent-teen driving agreements | 0.427516 |
| teen motor vehicle | 0.516002 |
|
| crash-related injuries | 0.398127 |
| car crashes | 0.441194 |
| teens | 0.413787 |
| motor vehicle crash | 0.399119 |
| parent-teen driving agreement | 0.627849 |
| driver licensing | 0.501187 |
| newly licensed phase | 0.396215 |
| dangerous driving situations | 0.423343 |
| teen passengers | 0.497317 |
| night-time crashes | 0.421529 |
| Night Driving Restrictions | 0.432909 |
| National Teen Driver | 0.554715 |
| new drivers | 0.375504 |
| fatal crashes | 0.518933 |
| safer drivers | 0.383622 |
| provisional license holders | 0.51168 |
| teen driver safety | 0.617908 |
| high school students | 0.397502 |
| minimum age | 0.417504 |
| beginner teen drivers | 0.503438 |
| key role | 0.410972 |
| comprehensive GDL systems | 0.615157 |
| Safe Teen Drivers | 0.527883 |
| Driver inexperience | 0.38176 |
|
CLICK HERE |
| 5078 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, September 07, 2009 |
null |
| endorsement | 0.306267 |
| current awareness | 0.321384 |
| findings | 0.248016 |
| Disease Control | 0.319343 |
| pathogenic avian influenza | 0.442956 |
| review | 0.220962 |
| CDC Knowledge | 0.573683 |
| Action Science Clips | 0.982377 |
| factual accuracy | 0.324003 |
| proposal | 0.221609 |
| Chief Science Officer | 0.438641 |
| conclusions | 0.224826 |
| article | 0.234875 |
| DHHS | 0.353708 |
| Human infection | 0.326394 |
| persons | 0.219848 |
| DISCLAIMER | 0.230365 |
| public domain | 0.327779 |
| Stephen B. Thacker | 0.678926 |
| items | 0.249173 |
| Centers | 0.219931 |
| components | 0.224726 |
| Articles | 0.220425 |
| methods | 0.219811 |
|
| storage | 0.220737 |
| Prevention | 0.219891 |
| inclusion | 0.222746 |
| responsibility | 0.220257 |
| omission | 0.231108 |
| public health | 0.428913 |
| views | 0.239541 |
| informational purposes | 0.312527 |
| national privacy protection | 0.425607 |
| public health literature | 0.417709 |
| permission | 0.225675 |
| B. Thacker CDC | 0.824626 |
| original authors | 0.316838 |
| way | 0.21975 |
| opinion | 0.238435 |
| non-CDC Websites | 0.316335 |
| original sources | 0.323354 |
| Ethical collection | 0.322806 |
| Vol. | 0.225041 |
| service | 0.222043 |
| public health data | 0.422803 |
| news sources | 0.314786 |
| report | 0.224764 |
| clinical issues | 0.325518 |
|
CLICK HERE |
| 5277 |
Centers for Disease Control and Prevention |
Html |
en |
Half of All States Have Smoke-Free Worksites, Restaurants and Bars: April 21, 2011 |
Half of All States Have Smoke-Free Worksites, Restaurants and Bars |
| CDC director Thomas | 0.330091 |
| smoke-free status | 0.304831 |
| Mortality Weekly Report | 0.323907 |
| smoke-free laws | 0.790048 |
| statewide smoking restrictions | 0.349519 |
| secondhand smoke exposure | 0.976888 |
| tobacco smoke—including secondhand | 0.411767 |
| comprehensive smoke-free laws | 0.735041 |
| health care costs | 0.290728 |
|
| states | 0.224496 |
| lung cancer deaths | 0.280295 |
| Chronic Disease Prevention | 0.271206 |
| private sector worksites | 0.414848 |
| State Tobacco Activities | 0.26325 |
| local smoke-free laws | 0.438459 |
| CDC report | 0.219353 |
| heart disease deaths | 0.284194 |
|
CLICK HERE |
| 5776 |
Centers for Disease Control and Prevention |
Html |
en |
Vinyl bromide - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 11840 |
Centers for Disease Control and Prevention |
Html |
en |
Public Health Research on Fragile X Syndrome |
The Centers for Disease Control and Prevention works with fragile X syndrome (FXS) clinicians and researchers to build a data resource to help answer important clinical care and public health research questions about this condition. |
| Fragile X Clinical | 0.466225 |
| partial data | 0.466027 |
| CDC | 0.487658 |
| FXS patient advocate | 0.760005 |
| individuals | 0.510986 |
| Disease Control | 0.49545 |
| mutation FXS | 0.794531 |
| broader research community | 0.489403 |
| autism spectrum disorder | 0.47386 |
| health research questions | 0.581161 |
| health professionals | 0.497143 |
| research community | 0.49177 |
| important clinical care | 0.503043 |
| fragile X specialty | 0.464501 |
| researchers | 0.493101 |
| Global Developmental Delays | 0.474128 |
| broader FXS research | 0.796956 |
| early identification | 0.521616 |
| FXS data collection | 0.822518 |
| FXS research | 0.823707 |
| FXS clinicians | 0.767264 |
| FXS patients | 0.730345 |
| intellectual disability | 0.541428 |
| FXS | 0.999082 |
| fragile X syndrome | 0.506446 |
|
| complex health challenges | 0.507511 |
| FXS population | 0.865677 |
| multiple data points | 0.509787 |
| co-occurring conditions | 0.500318 |
| FXS stakeholders | 0.751969 |
| Accessible Research Database | 0.498503 |
| follow-up longitudinal data | 0.507097 |
| FXS clinical care | 0.762426 |
| sensory integration issues | 0.498363 |
| public health knowledge | 0.566889 |
| CDC funds | 0.468318 |
| healthcare professionals | 0.55291 |
| public health | 0.667008 |
| latest FXS | 0.75082 |
| FXS referral | 0.739239 |
| future research efforts | 0.488088 |
| fragile X-associated disorders | 0.498556 |
| data resource | 0.476833 |
| CDC researchers | 0.468473 |
| families | 0.498014 |
| complete baseline data | 0.507249 |
| better understanding FXS | 0.808932 |
| public health data | 0.540126 |
| allied health professionals | 0.497019 |
|
CLICK HERE |
| 11850 |
Centers for Disease Control and Prevention |
Html |
en |
Pertussis | Whooping Cough | Clinical | Disease Specifics | CDC |
Pertussis: Disease Specifics |
| 1940s | 0.320892 |
| CDC | 0.346566 |
| bacteria | 0.336238 |
| United States | 0.409982 |
| pre-vaccine era | 0.401408 |
| alveolar macrophages | 0.406636 |
| acute infectious disease | 0.499315 |
| respiratory epithelial cells | 0.472417 |
| Page | 0.317276 |
| Research | 0.316979 |
| B. pertussis | 0.723725 |
| pertussis | 0.994496 |
| number | 0.318046 |
| 20th century | 0.409018 |
| genetic level | 0.39646 |
| immune response | 0.393884 |
| inflammation | 0.31952 |
| produces immunity | 0.398704 |
| underway | 0.321933 |
| childhood mortality | 0.413698 |
| recent changes | 0.392089 |
| toxin-mediated disease | 0.38966 |
|
| observational studies | 0.391402 |
| cases | 0.380789 |
| biologically active products | 0.470419 |
| tissues | 0.31889 |
| pertussis infection | 0.625866 |
| bacterium Bordetella pertussis | 0.817731 |
| gram-negative bacterium | 0.410527 |
| isolation | 0.317782 |
| peak | 0.317224 |
| major cause | 0.408439 |
| increase | 0.366794 |
| public health experts | 0.488558 |
| recent studies | 0.385168 |
| respiratory tract | 0.393703 |
| toxins | 0.31871 |
| common childhood diseases | 0.501716 |
| special media | 0.394341 |
| pertussis vaccine | 0.672913 |
| cilia | 0.349904 |
| incidence | 0.320313 |
| clinical features | 0.392508 |
|
CLICK HERE |
| 12337 |
Centers for Disease Control and Prevention |
Html |
en |
Prompt Use of Antivirals is Key this Flu Season | CDC Features |
Influenza activity in the United States is high overall and is likely to continue for weeks. Influenza A (H3N2) viruses have been most common, and the majority of H3N2 viruses analyzed this season are different from the H3N2 viruses in this season's flu vaccine. This may reduce how well the vaccine protects against those H3N2 viruses.
|
| Influenza activity | 0.542211 |
| CDC | 0.438556 |
| Mortality Weekly Report | 0.429669 |
| health care provider | 0.486967 |
| randomized controlled trials | 0.496481 |
| flu treatment | 0.507893 |
| influenza antiviral medications | 0.910237 |
| influenza confirmatory testing | 0.513985 |
| high risk patients | 0.422229 |
| patients | 0.435084 |
| flu illness | 0.574728 |
| flu antiviral drugs | 0.871297 |
| flu antivirals | 0.525104 |
| anti-influenza drugs | 0.400719 |
| antiviral recommendations | 0.568669 |
| annual influenza vaccination | 0.514492 |
| 15th press release | 0.428583 |
| available influenza | 0.464041 |
| high risk | 0.460142 |
| important background information | 0.408204 |
| Antiviral treatment | 0.511139 |
| Antiviral influenza | 0.637555 |
| vaccine production | 0.387788 |
| severe flu illness | 0.557424 |
|
| flu vaccine | 0.758224 |
| milder illness | 0.375493 |
| flu complications | 0.51987 |
| percent | 0.37989 |
| annual flu vaccine | 0.594621 |
| high-risk patients | 0.375013 |
| CDC qualitative research | 0.42622 |
| vaccine virus | 0.383999 |
| positive flu test | 0.561895 |
| vaccine viruses | 0.393156 |
| public health benefit | 0.409877 |
| low clinician awareness | 0.416214 |
| current flu season | 0.579193 |
| percent effectiveness | 0.379853 |
| antiviral drugs | 0.950849 |
| influenza antiviral drug | 0.646549 |
| past influenza seasons | 0.511414 |
| flu viruses | 0.544853 |
| people | 0.384503 |
| treatment efforts | 0.378793 |
| seasonal influenza illness | 0.548105 |
| influenza viruses | 0.482232 |
| CDC Health Update | 0.433204 |
| severe illness | 0.373511 |
|
CLICK HERE |
| 13491 |
Centers for Disease Control and Prevention |
Html |
en |
Use and Interpretation of a Rapid Respiratory SyncytialVirus Antigen Detection Test Among Infants Hospitalized in aNeonatal Intensive Care Unit - Wisconsin, March 2015 |
Lina I. Elbadawi, MD1,2; Thomas Haupt, MS2; Erik Reisdorf, MPH3; Tonya Danz3; Jeffrey P. Davis, MD2. |
| positive predictive value | 0.546499 |
| real-time polymerase chain | 0.531364 |
| asymptomatic neonate | 0.642831 |
| real-time PCR | 0.446498 |
| RSV infection | 0.769413 |
| nasopharyngeal specimens | 0.792925 |
| asymptomatic infants | 0.539351 |
| viral transport media | 0.50641 |
| hospital laboratory | 0.654979 |
| peak RSV season | 0.862936 |
| negative test | 0.435115 |
| Jeffrey P. Davis | 0.552996 |
| infant nasopharyngeal specimens | 0.705975 |
| nasopharyngeal swab | 0.990039 |
| neonate whose RRADT | 0.563897 |
| asymptomatic NICU patients | 0.68081 |
| Wisconsin State Laboratory | 0.54342 |
| Erik Reisdorf | 0.437358 |
| reported PPV | 0.481282 |
| infection outbreak | 0.456059 |
| 3Wisconsin State Laboratory | 0.518061 |
| widespread RSV infection | 0.724861 |
| different hospital room | 0.541306 |
| respiratory syncytial virus | 0.571763 |
|
| hospital laboratory RRADT | 0.549038 |
| asymptomatic patients | 0.52657 |
| 1Epidemic Intelligence Service | 0.510778 |
| Public Health | 0.66128 |
| multiplex respiratory virus | 0.537819 |
| personal identifying information | 0.501107 |
| Wisconsin Division | 0.538689 |
| symptomatic neonates | 0.476912 |
| characteristic clinical illness | 0.508118 |
| index patient | 0.437827 |
| test result interpretation | 0.535494 |
| neonatal intensive care | 0.550645 |
| positive test | 0.471461 |
| nasopharyngeal swab specimen | 0.964632 |
| asymptomatic neonates | 0.606225 |
| positive RRADT results | 0.579352 |
| RSV antigen detection | 0.718158 |
| Tonya Danz | 0.448809 |
| RSV subgroups | 0.593028 |
| Sixteen nasopharyngeal specimens | 0.748663 |
| RSV infection prevalence | 0.688686 |
| RRADT manufacturer | 0.444062 |
| Lina I. Elbadawi | 0.772056 |
| nasopharyngeal swab specimens | 0.952664 |
|
CLICK HERE |
| 14247 |
Centers for Disease Control and Prevention |
Html |
en |
Update: Providing Quality Family Planning Services -Recommendations from CDC and the U.S. Office of Population Affairs,2015 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| highest quality care | 0.649928 |
| CDC | 0.792441 |
| Human Services | 0.69326 |
| immunization practices | 0.833494 |
| Basic Infertility Services | 0.679031 |
| recommendations | 0.741686 |
| U.S. Department | 0.685173 |
| transmitted diseases treatment | 0.741132 |
| Services Administration | 0.653892 |
| Screening Services | 0.684433 |
| optimal screening intervals | 0.674242 |
| new CDC guidelines | 0.707782 |
| advisory committee | 0.817484 |
| American Society | 0.645068 |
| Practice Committee | 0.644804 |
| time QFP | 0.647582 |
| Preventive Services Task | 0.780226 |
| Morb Mortal Wkly | 0.734201 |
| blood pressure | 0.761942 |
| std treatment guidelines | 0.743301 |
| reproductive health | 0.65485 |
| family planning services | 0.800322 |
| clinical recommendations | 0.667006 |
| MMWR Recomm Rep | 0.988087 |
|
| CDC STD treatment | 0.708949 |
| USPSTF recommendations | 0.663454 |
| low risk | 0.694529 |
| Transmitted Disease Services | 0.685418 |
| U.S. Preventive Services | 0.787232 |
| diseases treatment guidelines | 0.748593 |
| family planning providers | 0.755958 |
| original QFP recommendation | 0.707006 |
| MMWR Morb Mortal | 0.738975 |
| family planning | 0.840503 |
| Sexually transmitted diseases | 0.741118 |
| Mortal Wkly Rep | 0.735129 |
| Preventive Health Services | 0.711233 |
| American College | 0.802482 |
| Providing Quality Family | 0.658067 |
| QFP recommendations | 0.732189 |
| original QFP recommendations | 0.71479 |
| family planning visit | 0.656601 |
| hiv prevention | 0.687229 |
| Services Task Force | 0.783403 |
| quality family planning | 0.774506 |
| previous USPSTF recommendation | 0.804406 |
| HBV infection | 0.666353 |
| Population Affairs | 0.759942 |
|
CLICK HERE |